Rare diseases
Investigational molecules
Locations
Back to Poland1 174 clinical trials in Zabrze, Poland across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study on the Safety of Ticagrelor and Aspirin in Patients with Acute Coronary Syndrome
PolandStudy on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis
PolandStudy of NNC0519-0130 and semaglutide in people with chronic kidney disease who are overweight or obese, with or without type 2 diabetes
PolandStudy on the Effects of Zasocitinib for Patients with Moderate to Severe Ulcerative Colitis
PolandStudy on Ustekinumab and Guselkumab for Children with Active Juvenile Psoriatic Arthritis
PolandStudy on Batoclimab for Treating Patients with Active Thyroid Eye Disease
PolandStudy on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis
PolandStudy on BI 706321 and Ustekinumab for Patients with Moderate to Severe Crohn's Disease
PolandStudy on Fenebrutinib and Teriflunomide for Adults with Relapsing Multiple Sclerosis
PolandStudy of RVU120 for Patients with Advanced Solid Tumors After Standard Treatments Have Failed
PolandStudy on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis
PolandStudy on the Safety and Tolerability of DNTH103 for Adults with Generalized Myasthenia Gravis
PolandThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials focusing on heart failure treatment and prevention, including studies of novel drug combinations like baxdrostat/dapagliflozin and sacubitril/valsartan. Research encompasses various cardiac conditions, from post-myocardial infarction care to atrial fibrillation management.
Multiple studies are examining innovative approaches to cardiac health management and prevention strategies.
Advanced clinical research in multiple sclerosis treatments, testing new therapies like frexalimab and ublituximab. Studies also include innovative approaches to treating Alzheimer's disease and chronic inflammatory demyelinating polyneuropathy.
Trials focus on improving patient outcomes and developing more effective treatment protocols.
Comprehensive studies addressing obesity management and diabetes control, particularly in adolescent populations. Research includes evaluation of new treatments like tirzepatide and innovative insulin therapies.
Research aims to develop more effective treatments for metabolic disorders across different age groups.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
